CRISPR Therapeutics
E1188105
UNEXPLORED
CRISPR Therapeutics is a biotechnology company focused on developing gene-editing therapies using CRISPR/Cas9 technology to treat serious diseases.
All labels observed (1)
| Label | Occurrences |
|---|---|
| CRISPR Therapeutics canonical | 1 |
How this entity was disambiguated
This entity first appeared as the object of triple T15982903 — resolving that mention is where its identity was fixed. The disambiguator weighed these candidate entities and picked the highlighted one (or “None”, minting a new entity). This is how homonymy is resolved: the same surface form can point to different entities.
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: CRISPR Therapeutics Context triple: [Vertex Pharmaceuticals, collaboratesWith, CRISPR Therapeutics]
-
A.
Editas Medicine
Editas Medicine is a biotechnology company focused on developing CRISPR-based gene-editing therapies to treat serious genetic diseases.
-
B.
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals is a biopharmaceutical company specializing in the development of RNA interference (RNAi)-based therapeutics for genetically defined diseases.
-
C.
Insitro
Insitro is a biotechnology company that uses machine learning and high-throughput biology to accelerate drug discovery and development.
-
D.
Flagship Pioneering
Flagship Pioneering is a venture creation firm and life sciences investment company known for founding and building innovative biotechnology companies, including Moderna.
-
E.
Horizon Discovery
Horizon Discovery is a biotechnology company specializing in gene editing and cell-based research tools used for drug discovery and development.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
NED2
Entity disambiguation (via description)
gpt-5-mini-2025-08-07
Target entity: CRISPR Therapeutics Target entity description: CRISPR Therapeutics is a biotechnology company focused on developing gene-editing therapies using CRISPR/Cas9 technology to treat serious diseases.
-
A.
Editas Medicine
Editas Medicine is a biotechnology company focused on developing CRISPR-based gene-editing therapies to treat serious genetic diseases.
-
B.
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals is a biopharmaceutical company specializing in the development of RNA interference (RNAi)-based therapeutics for genetically defined diseases.
-
C.
Insitro
Insitro is a biotechnology company that uses machine learning and high-throughput biology to accelerate drug discovery and development.
-
D.
Flagship Pioneering
Flagship Pioneering is a venture creation firm and life sciences investment company known for founding and building innovative biotechnology companies, including Moderna.
-
E.
Horizon Discovery
Horizon Discovery is a biotechnology company specializing in gene editing and cell-based research tools used for drug discovery and development.
- F. None of above. chosen
Referenced by (1)
Full triples — surface form annotated when it differs from this entity's canonical label.